ProfileGDS4718 / 232179_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 42% 51% 43% 42% 53% 52% 57% 39% 40% 40% 34% 48% 48% 61% 51% 32% 35% 57% 58% 60% 44% 45% 34% 27% 51% 45% 44% 77% 42% 60% 44% 52% 48% 39% 81% 68% 46% 45% 37% 38% 37% 66% 63% 65% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.083942
GSM549102patient 115, normal, homogenized [OPG study]5.5954351
GSM549104patient 119, normal, homogenized [OPG study]5.1143343
GSM549108patient 138, normal, homogenized [OPG study]5.1496742
GSM549119patient 077, normal, homogenized [OPG study]5.6875853
GSM549133patient 032, cancer, homogenized [OPG study]5.5821652
GSM549139patient 042, cancer, homogenized [OPG study]5.8909357
GSM549099patient 107, normal, homogenized [OPG study]4.9539339
GSM549109patient 139, normal, homogenized [OPG study]5.0036540
GSM549110patient 046, normal, homogenized [OPG study]4.9993140
GSM549114patient 063, normal, homogenized [OPG study]4.6878434
GSM549122patient 082, normal, homogenized [OPG study]5.4221548
GSM549134patient 033, cancer, homogenized [OPG study]5.3674348
GSM549136patient 036, cancer, homogenized [OPG study]6.1718161
GSM549140patient 044, cancer, homogenized [OPG study]5.5328751
GSM549111patient 047, normal, homogenized [OPG study]4.5837132
GSM549113patient 057, normal, homogenized [OPG study]4.6994435
GSM549132patient 031, cancer, homogenized [OPG study]5.9347957
GSM549137patient 038, cancer, homogenized [OPG study]6.0200958
GSM549142patient 047, cancer, homogenized [OPG study]6.2179560
GSM549100patient 110, normal, homogenized [OPG study]5.1988644
GSM549107patient 135, normal, homogenized [OPG study]5.2023145
GSM549115patient 068, normal, homogenized [OPG study]4.6634134
GSM549116patient 072, normal, homogenized [OPG study]4.4065927
GSM549120patient 078, normal, homogenized [OPG study]5.5428251
GSM549131patient 030, cancer, homogenized [OPG study]5.2094145
GSM549118patient 074, normal, homogenized [OPG study]5.1843844
GSM549129patient 027, cancer, homogenized [OPG study]7.5941977
GSM549123patient 088, normal, homogenized [OPG study]5.0499142
GSM549124patient 006, cancer, homogenized [OPG study]6.1304160
GSM549126patient 015, cancer, homogenized [OPG study]5.16244
GSM549128patient 025, cancer, homogenized [OPG study]5.6326252
GSM549103patient 117, normal, homogenized [OPG study]5.4607148
GSM549117patient 073, normal, homogenized [OPG study]4.9083539
GSM549138patient 041, cancer, homogenized [OPG study]8.0249981
GSM549141patient 045, cancer, homogenized [OPG study]6.7446768
GSM549130patient 028, cancer, homogenized [OPG study]5.3062846
GSM549101patient 111, normal, homogenized [OPG study]5.252545
GSM549105patient 128, normal, homogenized [OPG study]4.8644937
GSM549106patient 134, normal, homogenized [OPG study]4.8289738
GSM549112patient 048, normal, homogenized [OPG study]4.8459337
GSM549125patient 011, cancer, homogenized [OPG study]6.5793866
GSM549127patient 024, cancer, homogenized [OPG study]6.4245163
GSM549135patient 035, cancer, homogenized [OPG study]6.4979265